24/7 Patient Assistance: 760-405-8205

Tawee Tanvetyanon, MD,MPH

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

Moffitt Cancer Center

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

  • Bio & Insurance Information

    Dr. Tawee Tanvetyanon got his medical degree from Chulalongkorn University Faculty of Medicine and did his residency at Albert Einstein Medical Center. He succeeded in completing his fellowship at Stritch School of Medicine. Dr. Tanvetyanon is certified in hematology, medical oncology and also internal medicine. He has between 11 and 20 years of practice and is currently affiliated with Moffitt Cancer Center being one of the 28 doctors specialized in medical oncology.

    Insurance Accepted

    Aetna Choice POS IICignaFirst Health PPOHumanaUnited Healthcare

  • Education & Training

    dept_icon

    Chulalongkorn University Faculty of Medicine

    Medical School

    dept_icon

    Albert Einstein Medical Center

    Residency

    dept_icon

    Stritch School of Medicine

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Moffitt Cancer Center

    Languages: English/Spanish

    (888) 663-3488

    12902 USF Magnolia Drive

    Tampa, Florida 33612

    Read More
  • Publications & Memberships

    Dr. Tawee Tanvetyanon has contributed to 3 publications.

    Phase II Trial of Dasatinib for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and for Non-Adenoid Cystic Malignant Salivary Tumors

    Wong, S. J.,Karrison, T.,Hayes, D. N.,Kies, M. S.,Cullen, K. J.,Tanvetyanon, T.,Argiris, A.,Takebe, N.,Lim, D.,Saba, N. F.,Worden, F. P.,Gilbert, J.,Lenz, H. J.,Razak,...; Ann. Oncol.. 2015 Nov 26.

    See more >>

    Phase 2 Study of Concurrent Cetuximab Plus Definitive Thoracic Radiation Therapy Followed by Consolidation Docetaxel Plus Cetuximab in Poor Prognosis or Elderly Patien

    Dilling, T. J.,Extermann, M.,Kim, J.,Thompson, L. M.,Yue, B.,Stevens, C. W.,Antonia, S.,Gray, J.,Williams, C.,Haura, E.,Pinder-Schenck, M.,Tanvetyanon, T.,Kim, S.,Chia...; Int. J. Radiat. Oncol. Biol. Phys.. 2014 Sep 14.

    See more >>

    Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.

    Tanvetyanon, T.,Creelan, B. C.,Chiappori, A. A.; Cancer Control. 2013 Dec 21

    See more >>

    Memberships

    American Association for Cancer Research

    American Society of Clinical Oncology

    American Society of Hematology